Newbridge Financial Services Group’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31K | Hold |
292
| – | – | 0.01% | 608 |
|
|
2025
Q1 | $36.3K | Sell |
292
-176
| -38% | -$21.9K | 0.01% | 435 |
|
|
2024
Q4 | $57.6K | Hold |
468
| – | – | 0.01% | 373 |
|
|
2024
Q3 | $52.1K | Hold |
468
| – | – | 0.02% | 249 |
|
|
2024
Q2 | $50K | Hold |
468
| – | – | 0.02% | 371 |
|
|
2024
Q1 | $56.4K | Hold |
468
| – | – | 0.02% | 372 |
|
|
2023
Q4 | $57.6K | Buy |
468
+336
| +255% | +$41.3K | 0.03% | 364 |
|
|
2023
Q3 | $17.1K | Hold |
132
| – | – | 0.01% | 680 |
|
|
2023
Q2 | $16.4K | Hold |
132
| – | – | 0.01% | 751 |
|
|
2023
Q1 | $19.3K | Hold |
132
| – | – | 0.01% | 737 |
|
|
2022
Q4 | $21K | Hold |
132
| – | – | 0.01% | 707 |
|
|
2022
Q3 | $18K | Hold |
132
| – | – | 0.01% | 726 |
|
|
2022
Q2 | $21K | Hold |
132
| – | – | 0.01% | 643 |
|
|
2022
Q1 | $21K | Hold |
132
| – | – | 0.01% | 718 |
|
|
2021
Q4 | $17K | Sell |
132
-6
| -4% | -$773 | 0.01% | 778 |
|
|
2021
Q3 | $18K | Buy |
138
+6
| +5% | +$783 | 0.01% | 693 |
|
|
2021
Q2 | $23K | Buy |
132
+116
| +725% | +$20.2K | 0.01% | 735 |
|
|
2021
Q1 | $3K | Buy |
+16
| New | +$3K | ﹤0.01% | 1123 |
|